Tese de Doutorado do Dr. Felipe Coelho é publicada em periódico internacional
Artigo sobre escleroterapia com espuma é publicado na revista Dermatologic Surgery
Artigo da Tese de Doutorado do Dr. Felipe Coelho Neto
Dr. Felipe Coelho se inspira nos grandes nomes da Flebologia mundial, em especial aqueles que conduzem os estudos que norteiam nossas condutas no dia-a-dia.
E tem a grande aspiração de levar seus próprios resultados às grandes revistas nacionais e internacionais de Flebologia. No início de 2019, uma importante etapa se encerrou, com a publicação do resultado de sua Tese de Doutorado no Programa de Pós-Graduação em Ciências Médicas da Universidade de Brasília - UnB.
Desde 2011 estudando sobre escleroterapia, o artigo descreve os achados após o seguimento de 12 meses de pacientes submetidos ao tratamento de escleroterapia com espuma, avaliando parâmetros objetivos por meio de fotopletismografia e subjetivos por meio da análise de questionários de qualidade de vida. Abaixo segue o abstract do artigo publicado na revista Dermatologic Surgery (https://journals.lww.com/dermatologicsurgery/Abstract/publishahead/Impact_of_Great_Saphenous_Vein_Foam_Sclerotherapy.98245.aspx)
BACKGROUND Ultrasound-guided foam sclerotherapy (UGFS) for treatment of chronic venous insufficiency (CVI) has been attracting significant interest over the past 20 years. It is a minimally invasive technique that comprises a safe treatment option and has yielded good results, especially in cases of advanced disease, with high rates of wound healing.
OBJECTIVE To examine clinical, ultrasound, and photoplethysmography outcomes after a 1-year follow-up of UGFS for CVI.
MATERIALS AND METHODS Twenty-nine legs classified as C4, C5, or C6 of the CEAP classification were included. Patients answered the VEINES questionnaire on quality of life and symptoms. and their venous filling time (VFT) was measured using photoplethysmography before and 45, 180, and 360 days after treatment of CVI with UGFS.
RESULTS The results showed statistically significant improvements in VEINES quality-of-life and symptom scores and in VFT measured by photoplethysmography and a reduction in great saphenous vein diameter (p < .0001) at 45, 180, and 360 days after treatment with UGFS.
CONCLUSION Ultrasound-guided foam sclerotherapy demonstrated efficacy and resulted in high satisfaction levels, confirmed by improvement in questionnaire scores, venous refilling time, and ultrasound findings.